Ingrid Zerbe
Bedrijfssecretaris bij INTELGENX TECHNOLOGIES CORP.
Vermogen: 975 858 $ op 30-04-2024
Profiel
Ingrid Zerbe is the founder and director of Intelgenx Corp., which was founded in 2003.
She is currently working as a secretary at IntelGenx Technologies Corp.
since 2006.
In terms of education, she has an undergraduate degree from the University of Dortmund.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 13-03-2023 | 5 158 221 ( inf% ) | 861 423 $ | 30-04-2024 | |
| 29-01-2024 | 685 238 ( 0.39% ) | 114 435 $ | 30-04-2024 |
Actieve functies van Ingrid Zerbe
| Bedrijven | Functie | Begin |
|---|---|---|
| INTELGENX TECHNOLOGIES CORP. | Bedrijfssecretaris | 01-04-2006 |
Intelgenx Corp.
 Intelgenx Corp. Pharmaceuticals: MajorHealth Technology Intelgenx Corp. develops oral-controlled release pharmaceutical products. The firm offers pharmaceuticals services to pharmaceutical partners, including R&D, analytical method development, clinical monitoring, IP and regulatory services. The company was founded in 2003 and is headquartered in Saint-Laurent, Canada. | Oprichter | 12-10-2010 |
Opleiding van Ingrid Zerbe
| University of Dortmund | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| INTELGENX TECHNOLOGIES CORP. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Intelgenx Corp.
Intelgenx Corp. Pharmaceuticals: MajorHealth Technology Intelgenx Corp. develops oral-controlled release pharmaceutical products. The firm offers pharmaceuticals services to pharmaceutical partners, including R&D, analytical method development, clinical monitoring, IP and regulatory services. The company was founded in 2003 and is headquartered in Saint-Laurent, Canada. | Health Technology |
